文献速递前列腺癌

经会阴与经直肠靶向活检在电磁追踪MR/US融合引导下检测临床显著前列腺癌的比较

Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer.
PubMed 文献 · Urology · 2020-09-18

这项前瞻性非随机单术者系列研究比较了经会阴(TP-TBx)与经直肠(TR-TBx)靶向前列腺活检在电磁追踪MR/US融合引导下检测临床显著前列腺癌(csPCa)的效果。

要点

  • 经会阴与经直肠靶向活检检测任何前列腺癌和临床显著前列腺癌无显著差异。
  • TP-TBx和TR-TBx的csPCa检出率分别为59%和54%。

核心结论

  • 经会阴靶向活检与经直肠融合引导方法在检测任何前列腺癌和临床显著前列腺癌方面相当。

研究设计与样本

  • 前瞻性非随机单术者系列研究(NCT04026763),比较168例经会阴靶向活检患者与211例经直肠靶向活检患者,均使用电磁追踪MR/US融合引导平台。

主要发现

  • TP-TBx和TR-TBx的csPCa检出率分别为59%和54%。

临床怎么用

  • 经会阴靶向活检可作为经直肠融合引导靶向活检的替代方法,两者对前列腺癌和临床显著前列腺癌的检出率相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare transperineal (TP-TBx) and transrectal (TR-TBx) targeted prostate biopsy in a prospective non randomized single surgeon series of MR/US fusion-guided targeted biopsy performed using an electromagnetic tracking platform (NCT04026763). MATERIALS AND METHODS: In this single-institution prospective study, 168 patients who underwent transperineal systematic 12-core biopsy and TP-TBx with electromagnetic tracking (UroNav, Invivo, Gainesville, FL) were compared to 211 patients who underwent a similar procedure by a transrectal approach. Univariate and multivariate analyses were used to assess if biopsy technique impacted all cancer detection rates or clinically significant (Gleason score >3+4) cancer detection rates. RESULTS: Patients who underwent TP-TBx were older (68 vs 65 y, P = .014), with a slightly higher rate of PI-RADSv2.0 score (39% vs 28%, P = .039) and higher lesion volume on mpMRI (0.54 vs 0.41 cc, P = .039). The rates of CS disease detection by TP-TBx and TR-TBx were 59% and 54%, respectively. In a multivariate analysis adjusting for PSA, previous biopsy status, prostate volume, PI-RADS score, lesion volume, and lesion location, there was no statistically significant difference in likelihood to detect any PCa (OR, 0.98; 95% CI, 0.56-1.71; P = .940) or CS PCa (OR, 0.94, 95% CI, 0.58-1.51; P = .791). CONCLUSION: Transperineal targeted biopsy with electromagnetic-tracking is comparable to the transrectal fusion-guided approach in the detection of any PCa and csPCa cancer.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Winoker JS, Wajswol E, Falagario U, et al. Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer. Urology. 2020. PMID: 32956688. doi:10.1016/j.urology.2020.07.072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。